PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSONS DISEASE IN THE UNITED STATES
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74019-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)74019-5/fulltext
Section Title :
Section Order :
513
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74019-5&doi=10.1016/S1098-3015(10)74019-5